06:33 AM EST, 03/07/2025 (MT Newswires) -- Anika Therapeutics ( ANIK ) said Friday it completed the all-cash sale of its Parcus Medical business to Medacta.

Financial terms were not disclosed.

Anika President and Chief Executive Cheryl R. Blanchard said the sale allows the company to focus on its core hyaluronic acid technology.

Anika said it has agreed to work with Medacta post-sale to ease the transition for employees, distributors, medical customers, and patients.